Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The aim of this study is to evaluate the outcome of occult breast cancer (OBC) in patients with axillary presentation overall and according to the immunohistochemically defined tumour subtypes. We reviewed information on 15,490 consecutive primary breast cancer patients, who underwent surgery at the European institute of oncology between September 1997 and December 2008. Patients with OBC were compared with an equal number of patients with small invasive breast carcinomas (pT1) observed at the same institution during the same period, matched for year of surgery, age, nodal status and biological features. Eighty patients with OBC (study group) and 80 patients with early breast cancer (control group) were identified. There was no significant difference in the disease-free survival (5 years DFS 66 vs. 68% P = 0.91) and the overall survival (5 years OS 80 and 86% P = 0.99) between the OBC and control groups. A statistically significant worse outcome was observed within the group of OBC for patients with more than four involved lymph nodes and with triple negative tumours. The outcome of OBC patients is comparable with that of matched patients with small sized breast cancer. High risk of relapse and death was observed in OBC patients with triple negative tumours and extensive nodal involvement.

Original languageEnglish
Pages (from-to)867-875
Number of pages9
JournalBreast Cancer Research and Treatment
Volume129
Issue number3
DOIs
Publication statusPublished - Oct 2011

Fingerprint

Breast Neoplasms
Neoplasms
Control Groups
Disease-Free Survival
Lymph Nodes
Recurrence
Survival

Keywords

  • Axillary
  • Breast cancer
  • Triple negative

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

@article{c3054272da4e472da9bf4ce416d30011,
title = "Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation",
abstract = "The aim of this study is to evaluate the outcome of occult breast cancer (OBC) in patients with axillary presentation overall and according to the immunohistochemically defined tumour subtypes. We reviewed information on 15,490 consecutive primary breast cancer patients, who underwent surgery at the European institute of oncology between September 1997 and December 2008. Patients with OBC were compared with an equal number of patients with small invasive breast carcinomas (pT1) observed at the same institution during the same period, matched for year of surgery, age, nodal status and biological features. Eighty patients with OBC (study group) and 80 patients with early breast cancer (control group) were identified. There was no significant difference in the disease-free survival (5 years DFS 66 vs. 68{\%} P = 0.91) and the overall survival (5 years OS 80 and 86{\%} P = 0.99) between the OBC and control groups. A statistically significant worse outcome was observed within the group of OBC for patients with more than four involved lymph nodes and with triple negative tumours. The outcome of OBC patients is comparable with that of matched patients with small sized breast cancer. High risk of relapse and death was observed in OBC patients with triple negative tumours and extensive nodal involvement.",
keywords = "Axillary, Breast cancer, Triple negative",
author = "Emilia Montagna and Vincenzo Bagnardi and Nicole Rotmensz and Giuseppe Viale and Giuseppe Cancello and Manuelita Mazza and Anna Cardillo and Raffaella Ghisini and Viviana Galimberti and Paolo Veronesi and Simonetta Monti and Alberto Luini and Raviele, {Paola Rafaniello} and Mastropasqua, {Mauro Giuseppe} and Aron Goldhirsch and Marco Colleoni",
year = "2011",
month = "10",
doi = "10.1007/s10549-011-1697-6",
language = "English",
volume = "129",
pages = "867--875",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York LLC",
number = "3",

}

TY - JOUR

T1 - Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation

AU - Montagna, Emilia

AU - Bagnardi, Vincenzo

AU - Rotmensz, Nicole

AU - Viale, Giuseppe

AU - Cancello, Giuseppe

AU - Mazza, Manuelita

AU - Cardillo, Anna

AU - Ghisini, Raffaella

AU - Galimberti, Viviana

AU - Veronesi, Paolo

AU - Monti, Simonetta

AU - Luini, Alberto

AU - Raviele, Paola Rafaniello

AU - Mastropasqua, Mauro Giuseppe

AU - Goldhirsch, Aron

AU - Colleoni, Marco

PY - 2011/10

Y1 - 2011/10

N2 - The aim of this study is to evaluate the outcome of occult breast cancer (OBC) in patients with axillary presentation overall and according to the immunohistochemically defined tumour subtypes. We reviewed information on 15,490 consecutive primary breast cancer patients, who underwent surgery at the European institute of oncology between September 1997 and December 2008. Patients with OBC were compared with an equal number of patients with small invasive breast carcinomas (pT1) observed at the same institution during the same period, matched for year of surgery, age, nodal status and biological features. Eighty patients with OBC (study group) and 80 patients with early breast cancer (control group) were identified. There was no significant difference in the disease-free survival (5 years DFS 66 vs. 68% P = 0.91) and the overall survival (5 years OS 80 and 86% P = 0.99) between the OBC and control groups. A statistically significant worse outcome was observed within the group of OBC for patients with more than four involved lymph nodes and with triple negative tumours. The outcome of OBC patients is comparable with that of matched patients with small sized breast cancer. High risk of relapse and death was observed in OBC patients with triple negative tumours and extensive nodal involvement.

AB - The aim of this study is to evaluate the outcome of occult breast cancer (OBC) in patients with axillary presentation overall and according to the immunohistochemically defined tumour subtypes. We reviewed information on 15,490 consecutive primary breast cancer patients, who underwent surgery at the European institute of oncology between September 1997 and December 2008. Patients with OBC were compared with an equal number of patients with small invasive breast carcinomas (pT1) observed at the same institution during the same period, matched for year of surgery, age, nodal status and biological features. Eighty patients with OBC (study group) and 80 patients with early breast cancer (control group) were identified. There was no significant difference in the disease-free survival (5 years DFS 66 vs. 68% P = 0.91) and the overall survival (5 years OS 80 and 86% P = 0.99) between the OBC and control groups. A statistically significant worse outcome was observed within the group of OBC for patients with more than four involved lymph nodes and with triple negative tumours. The outcome of OBC patients is comparable with that of matched patients with small sized breast cancer. High risk of relapse and death was observed in OBC patients with triple negative tumours and extensive nodal involvement.

KW - Axillary

KW - Breast cancer

KW - Triple negative

UR - http://www.scopus.com/inward/record.url?scp=80052580353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052580353&partnerID=8YFLogxK

U2 - 10.1007/s10549-011-1697-6

DO - 10.1007/s10549-011-1697-6

M3 - Article

C2 - 21822638

AN - SCOPUS:80052580353

VL - 129

SP - 867

EP - 875

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 3

ER -